AIP.NASDAQArteris, INC

Form 4: Arteris CEO Sells 40,000 Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Arteris, Inc. President and CEO, K. Charles Janac, sold 40,000 shares of common stock for approximately $16.46 per share under a pre-arranged trading plan.

Summary

  • K. Charles Janac, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported a sale of common stock.
  • The transaction involved the disposition of 40,000 shares of Common Stock.
  • The shares were sold at a weighted average price of $16.4618 per share, with individual sales prices ranging from $16.25 to $16.65.
  • The transaction was executed on December 4, 2025.
  • This sale was conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Janac on March 5, 2025.
  • Following the transaction, Mr. Janac directly owns 158,455 shares of Common Stock.
  • Indirect beneficial ownership includes 9,599,071 shares held by Bayview Legacy, LLC, and 56,252 shares held by Charles and Lydia Janac Trust.

Sentiment

Score: 5

Explanation: The sale of shares by a CEO could be seen as a slight negative, but the fact that it was executed under a pre-arranged 10b5-1 plan mitigates concerns about its timing or motivation, making the overall sentiment neutral.

Positives

  • The sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on recent material non-public information.

Negatives

  • Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces management's direct equity stake.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This insider transaction report is specific to Arteris, Inc. and its CEO. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

  • Not applicable. This filing reports an individual insider stock transaction and does not contain information suitable for comparison to global benchmarks or specific comparable companies/projects.

Related Party Transactions

  • The transaction involves the sale of shares by the President and CEO, K. Charles Janac, who is a related party to Arteris, Inc. This is a standard disclosure for insider transactions.

Stakeholder Impact

  • Shareholders: May interpret the insider sale differently; some may view it as a normal part of financial planning, while others might see it as a signal, despite the 10b5-1 plan.
  • Employees: No direct impact mentioned.
  • Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

DateDescription
2025-03-05Date Rule 10b5-1 trading plan was adopted by K. Charles Janac.
2025-12-04Date of common stock transaction (sale of 40,000 shares).
2025-12-08Date the Form 4 was signed.

Recommendation

hold

While insider selling can sometimes be a negative signal, this transaction was conducted under a pre-arranged 10b5-1 plan, which suggests it's part of the insider's personal financial planning rather than a reaction to new, negative company-specific information. A single transaction of this nature, especially under a 10b5-1 plan, typically does not warrant a strong change in investment recommendation without additional context from the company's financial performance or strategic outlook.

Keywords

Arteris Inc., AIP, K. Charles Janac, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CEO, Director, 10% Owner

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.